A study found prenatal #OpioidUse is linked to higher maternal morbidity, including hypertensive disorders and transfusion needs, alongside worse infant outcomes. Findings highlight risks beyond neonatal effects. #MaternalHealth
Full video: www.contemporaryobgyn.net/view/jamie-l...
A study found distinct cervicovaginal microbiota patterns linked to frozen embryo transfer success in women with #endometriosis, suggesting the uterine microenvironment may influence implantation beyond embryo quality. #Infertility
Read more: www.contemporaryobgyn.net/view/bacteri...
Researchers report accelerating annual increases in #GestationalDiabetes, with neighborhood deprivation emerging as a potential risk factor linked to higher rates and long-term cardiometabolic risk. #MaternalOutcomes
Read more: www.contemporaryobgyn.net/view/us-gest...
In the PREVENT-PE trial, women offered risk-stratified early-term birth had lower rates of #preeclampsia vs usual care, with similar maternal and neonatal outcomes. #PregnancyResearch
Read more: www.contemporaryobgyn.net/view/planned...
In an interview with Contemporary OB/GYN, Elisabeth McClymont, PhD, discussed study findings showing #COVID19 vaccination during pregnancy reduced hospitalization for severe disease by 62% and ICU admission by ~90%. #vaccineswork
Full video: www.contemporaryobgyn.net/view/elisabe...
New evidence-based guidelines outline week-by-week strategies for managing antiseizure medications during and after pregnancy, offering clinicians a clear roadmap to support healthy pregnancies in women with #epilepsy. #PregnancyCare
Read more: www.contemporaryobgyn.net/view/pregnan...
A study found higher rates of maternal and infant infection among pregnancies with opioid-related diagnoses. Analysis of 5.5M California births showed rising prevalence and increased maternal and neonatal morbidity. #NeonatalHealth #OpioidUse
Read more: www.contemporaryobgyn.net/view/opioid-...
A large trial found that mid–second-trimester maternal blood biomarker screening with targeted preventive care significantly improved #NeonatalOutcomes in pregnancies otherwise considered low risk for preterm birth. #MaternalFetalMedicine
Read more: www.contemporaryobgyn.net/view/pretrm-...
Researchers report no convincing evidence that oestrogen-only or combined MHT meaningfully alters dementia risk in postmenopausal women, highlighting key evidence gaps for future study. #CognitiveHealth #Postmenopause
Read more: www.contemporaryobgyn.net/view/no-evid...
A study found women with high- and intermediate-penetrance breast cancer genes were more often identified through criteria-independent genetic testing, highlighting limits of family history–based guidelines. #BreastCancer #GeneticTesting
Read more: www.contemporaryobgyn.net/view/broader...
A phase 1 trial from Cleveland Clinic showed a novel preventive vaccine for triple-negative breast cancer induced an immune response in 74% of participants, with a favorable safety and tolerability profile. #BreastCancer #ClinicalTrial
Read more: www.contemporaryobgyn.net/view/phase-1...
A study found HPV vaccination was linked to lower odds of high-grade vulvar and vaginal lesions, with a 37-fold risk reduction in vaccinated vs unvaccinated women.
#HPVVaccine #CancerPrevention
Read more: www.contemporaryobgyn.net/view/hpv-vac...
COVID-19 vaccination during pregnancy significantly lowers risks of severe illness, ICU admission, and preterm birth, with benefits observed across Delta and Omicron variants. #PregnancyHealth #COVID19Vaccine
Read more: www.contemporaryobgyn.net/view/covid-1...
FDA approvals in 2025 marked major progress in women’s health, expanding access to care and improving diagnostic accuracy across the reproductive lifespan. #WomensHealth #FDA #HealthPolicy
Read more: www.contemporaryobgyn.net/view/top-fda...
FDA revisions to menopausal #HormoneTherapy labeling in 2025 removed several boxed warnings, while nonhormonal options continue to grow. Emerging therapies aim to personalize VMS treatment based on safety and efficacy. #Menopause
Read more: www.contemporaryobgyn.net/view/new-non...
From FDA-approved #UUI treatment to #epilepsy challenges in motherhood check out all the stories from Contemporary OB/GYN you might have missed between December 15 & December 19, 2025.
Read more: www.contemporaryobgyn.net/view/contemp...
In a recent video, Joshua Hare, MD, FACC, discusses female #SexualDysfunction, noting it affects ~40% of postmenopausal women and is often underrecognized despite significant impacts on quality of life. #Menopause
Full video: www.contemporaryobgyn.net/view/joshua-...
A meta-analysis found that adding magnetic bead auricular point therapy, electroacupuncture, or prophylactic steroids to #EpiduralAnalgesia significantly reduced epidural-related maternal fever risk. #LaborAndDelivery
Read more: www.contemporaryobgyn.net/view/adjunct...
A study found women ≥65 years have higher odds of late-stage #CervicalCancer vs younger women, despite guidelines allowing screening cessation after adequate prior screening. #CancerScreening
Read more: www.contemporaryobgyn.net/view/late-st...
A new meta-analysis found transabdominal cervical #cerclage was associated with lower perinatal mortality and #PretermBirth rates vs transvaginal cerclage, with low overall certainty of evidence.
Read more: www.contemporaryobgyn.net/view/transab...
A study found #IronDeficiency is significantly more common in adolescents with heavy #MenstrualBleeding, affecting over half of those with the condition compared with about one-quarter without it.
Read more: www.contemporaryobgyn.net/view/heavy-m...
The FDA has granted 510(k) clearance to the FemVue Controlled device for assessing fallopian tube status. The device combines FemVue and FemChec technologies and uses alternating saline and air contrast during #ultrasound. #MedicalDevices
Read more: www.contemporaryobgyn.net/view/fda-cle...
Acute heavy #MenstrualBleeding is linked to increased red blood cell transfusion use and higher treatment costs, according to a recent study. #WomensHealth
Read more: www.contemporaryobgyn.net/view/high-co...
The FDA has granted 510(k) clearance to the Revi System for long-term management of urgency #UrinaryIncontinence. The wearable device features a simplified design and adjustable control to support personalized therapy. #MedTech
Read more: www.contemporaryobgyn.net/view/fda-gra...
From preventing #CervicalCancer to managing #PostPartumDepression, check out all the stories from Contemporary OB/GYN you might have missed between December 8 & December 12, 2025.
Read more: www.contemporaryobgyn.net/view/contemp...
First-trimester ultrasounds can detect serious fetal anomalies earlier than standard second-trimester scans, a UK study of over 1M pregnancies shows. Early detection varies widely by hospital type and protocol. #PrenatalCare #FetalHealth
Read more: www.contemporaryobgyn.net/view/early-u...
A meta-analysis finds continuing #metformin through the first trimester in women with #PCOS is linked to higher clinical pregnancy rates and a trend toward lower miscarriage risk vs placebo or no treatment.
Read more: www.contemporaryobgyn.net/view/first-t...
Studies confirm #HPV vaccination directly prevents cervical cancer. Vaccinating before age 16 reduces incidence by ~80%, with countries reporting zero cases in fully vaccinated early-adolescent cohorts. #Vaccines
Full video: www.contemporaryobgyn.net/view/jo-morr...
New findings show brexanolone delivered rapid, sustained improvements in depressive and anxiety symptoms in postpartum depression, with benefits lasting up to 12 months and no serious adverse events reported. #PPD #MaternalHealth
Full video: www.contemporaryobgyn.net/view/brexano...
Nonhormonal therapies for menopausal hot flashes are changing care. Fezolinetant and elinzanetant target brain pathways, offering effective relief for women who can’t take estrogen. #MenopauseCare #HotFlashes
Full video: www.contemporaryobgyn.net/view/genevie...
